{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:35:12Z","timestamp":1792128912701,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hebei Province","award":["H2022423317"],"award-info":[{"award-number":["H2022423317"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81803762"],"award-info":[{"award-number":["81803762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018622","name":"Supporting Plan for 100 Excellent Innovative Talents in Colleges and Universities of Hebei Province","doi-asserted-by":"crossref","award":["SLRC2019044"],"award-info":[{"award-number":["SLRC2019044"]}],"id":[{"id":"10.13039\/501100018622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Talent Training Funding Project of Hebei Province","award":["A201901037"],"award-info":[{"award-number":["A201901037"]}]},{"name":"Natural Science Foundation of Shandong Province, China","award":["ZR2021MH123"],"award-info":[{"award-number":["ZR2021MH123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Septic cardiomyopathy is characterized by oxidative stress and inflammation, and accounts for its associated high mortality. Mangiferin is a naturally occurring xanthonoid found abundantly in\n                      <jats:italic>Anemarrhena<\/jats:italic>\n                      <jats:italic>asphodeloides<\/jats:italic>\n                      Bunge, a traditional Chinese herb widely used for treatment of cardiovascular diseases. This study was designed to investigate the cardioprotective role of mangiferin against sepsis-induced heart injury with a focus on mitochondrial DNA (mtDNA) release and cGAS-STING pathway-related inflammation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The septic cardiomyopathy model in mice was established by intraperitoneal injection of LPS (10\u00a0mg\/kg). Cardiac Nrf2 in septic mice was knocked down with AAV9-CTNT-Nrf2 shRNA to confirm the activity of mangiferin. Cardiomyocytes were cultured with LPS for further in vitro studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Oral administration of mangiferin enhanced the survival of mice against endotoxin-induced insult. When LPS challenge impaired cardiac structural integrity, mangiferin reduced macrophage recruitment in the heart and inhibited the gene expression of pro-inflammatory cytokines. In the septic heart, mangiferin increased Nrf2 protein expression, thereby protecting the heart from oxidative damage. Mechanistically, mangiferin increased Nrf2 protein abundance by promoting Keap-1 degradation, which in turn prevented Nrf2 from undergoing proteasomal degradation. Unlike nuclear DNA (nDNA), mitochondrial DNA (mtDNA) acts as a ligand to induce toll-like receptor (TLR) activation once released into the cytoplasm. By protecting mitochondrial membrane integrity, mangiferin combated oxidative stress to prevent mitochondrial fragmentation and prevented the opening of mitochondrial permeability transition pore (mPTP) and the collapse of mitochondrial membrane potential in a manner this is dependent on Nrf2 availability. These effects were, however, blocked in the presence of a special Nrf2 inhibitor, ML385. Similar to TLR4, TLR9 is a member of the damage-associated molecular patterns (DAMPs). It can induce immune response through STING\/IRF3 signaling. In septic mouse heart, mangiferin inhibited cGAS activity, deactivated STING\/IRF3 signaling via dephosphorylation and resultantly suppressed interferon response due to limited mtDNA leakage. In cultured cardiomyocytes, mangiferin blocked STING\/IRF3 signaling cascades in a Nrf2-dependent manner. Cardiac knockdown of Nrf2 with AAV9-CTNT-Nrf2 shRNA in septic mice demonstrated that Nrf2 deficiency diminished the inhibitory effects of mangiferin on cGAS-STING pathway-related inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Through Nrf2 activation, mangiferin ameliorates mitochondrial dysfunction to block mtDNA release and subsequent cGAS-STING pathway-related inflammation, resultantly protecting the heart against septic insult. These events suggest the potential in the treatment of heart injury from the perspective of mitochondrial protection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01329-9","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:51:02Z","timestamp":1769136662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mangiferin inhibits cGAS-STING pathway-related inflammation via Nrf2 activation to protect against sepsis-induced heart injury"],"prefix":"10.1186","volume":"21","author":[{"given":"Junna","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"1329_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","volume":"155","author":"L Martin","year":"2019","unstructured":"Martin L, Derwall M, Al Zoubi S, Zechendorf E, Reuter DA, Thiemermann C, et al. The septic heart: current understanding of molecular mechanisms and clinical implications. Chest. 2019;155:427\u201337.","journal-title":"Chest"},{"key":"1329_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108264","volume":"210","author":"V Kumar","year":"2020","unstructured":"Kumar V. Sepsis roadmap: what we know, what we learned, and where we are going. Clin Immunol. 2020;210:108264.","journal-title":"Clin Immunol"},{"key":"1329_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101771","volume":"38","author":"Y Li","year":"2021","unstructured":"Li Y, Feng YF, Liu XT, Li YC, Zhu HM, Sun MR, et al. Songorine promotes cardiac mitochondrial biogenesis via Nrf2 induction during sepsis. Redox Biol. 2021;38:101771.","journal-title":"Redox Biol"},{"key":"1329_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4076348","volume":"2017","author":"A Durand","year":"2017","unstructured":"Durand A, Duburcq T, Dekeyser T, Neviere R, Howsam M, Favory R, et al. Involvement of mitochondrial disorders in septic cardiomyopathy. Oxid Med Cell Longev. 2017;2017:4076348.","journal-title":"Oxid Med Cell Longev"},{"key":"1329_CR5","doi-asserted-by":"publisher","first-page":"R1177","DOI":"10.1016\/j.cub.2017.09.015","volume":"27","author":"AJ Roger","year":"2017","unstructured":"Roger AJ, Mu\u00f1oz-G\u00f3mez SA, Kamikawa R. The origin and diversification of mitochondria. Curr Biol. 2017;27:R1177\u201392.","journal-title":"Curr Biol"},{"key":"1329_CR6","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949799","volume":"21","author":"JS Riley","year":"2020","unstructured":"Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020;21:e49799.","journal-title":"EMBO Rep"},{"key":"1329_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101215","volume":"24","author":"N Li","year":"2019","unstructured":"Li N, Zhou H, Wu H, Wu Q, Duan M, Deng W, et al. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol. 2019;24:101215.","journal-title":"Redox Biol"},{"key":"1329_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-016-0553-6","volume":"111","author":"M Bliks\u00f8en","year":"2016","unstructured":"Bliks\u00f8en M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, et al. Extracellular mtDNA activates NF-\u03baB via toll-like receptor 9 and induces cell death in cardiomyocytes. Basic Res Cardiol. 2016;111:42.","journal-title":"Basic Res Cardiol"},{"key":"1329_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0378-8741(01)00326-9","volume":"78","author":"N Makare","year":"2001","unstructured":"Makare N, Bodhankar S, Rangari V. Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J Ethnopharmacol. 2001;78:133\u20137.","journal-title":"J Ethnopharmacol"},{"key":"1329_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00394-011-0252-x","volume":"51","author":"L M\u00e1rquez","year":"2012","unstructured":"M\u00e1rquez L, Garc\u00eda-Bueno B, Madrigal JL, Leza JC. Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur J Nutr. 2012;51:729\u201339.","journal-title":"Eur J Nutr"},{"key":"1329_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejphar.2015.12.006","volume":"770","author":"CW Pan","year":"2016","unstructured":"Pan CW, Pan ZZ, Hu JJ, Chen WL, Zhou GY, Lin W, et al. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Eur J Pharmacol. 2016;770:85\u201391.","journal-title":"Eur J Pharmacol"},{"key":"1329_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11596-021-2371-9","volume":"41","author":"ZZ Qin","year":"2021","unstructured":"Qin ZZ, Ruan J, Lee MR, Sun K, Chen P, Chen Y, et al. Mangiferin promotes bregs level, activates Nrf2 antioxidant signaling, and inhibits proinflammatory cytokine expression in murine splenic mononuclear cells in vitro. Curr Med Sci. 2021;41:454\u201364.","journal-title":"Curr Med Sci"},{"key":"1329_CR13","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/jcmm.16329","volume":"25","author":"L Chen","year":"2021","unstructured":"Chen L, Li S, Zhu J, You A, Huang X, Yi X, et al. Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1\/FoxO3a pathway. J Cell Mol Med. 2021;25:2944\u201355.","journal-title":"J Cell Mol Med"},{"key":"1329_CR14","volume":"249","author":"T Jiang","year":"2020","unstructured":"Jiang T, Han F, Gao G, Liu M. Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1\/FoxO3a pathway. J Cell Mol Med. 2020;249:117476.","journal-title":"J Cell Mol Med"},{"key":"1329_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104845","volume":"157","author":"J Song","year":"2020","unstructured":"Song J, Meng Y, Wang M, Li L, Liu Z, Zheng K, et al. Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate. Pharmacol Res. 2020;157:104845.","journal-title":"Pharmacol Res"},{"key":"1329_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01660-9","volume":"8","author":"J Wan","year":"2023","unstructured":"Wan J, Zhang Z, Wu C, Tian S, Zang Y, Jin G, et al. Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012\/9456. Signal Transduct Target Ther. 2023;8:414.","journal-title":"Signal Transduct Target Ther"},{"key":"1329_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308769","volume":"11","author":"S Yu","year":"2024","unstructured":"Yu S, Sun Z, Ju T, Liu Y, Mei Z, Wang C, et al. The m7G methyltransferase mettl1 drives cardiac hypertrophy by regulating srsf9-mediated splicing of NFATc4. Adv Sci (Weinh). 2024;11:e2308769.","journal-title":"Adv Sci (Weinh)"},{"key":"1329_CR18","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He F, Xiaoli Ru, Wen T. NRF2, a transcription factor for stress response and beyond. Int J Mol Sci. 2020;21:4777.","journal-title":"Int J Mol Sci"},{"key":"1329_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139:323\u201334.","journal-title":"Gastroenterology"},{"key":"1329_CR20","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020;25:5474.","journal-title":"Molecules"},{"key":"1329_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/toxsci\/kfn079","volume":"104","author":"WO Osburn","year":"2008","unstructured":"Osburn WO, Yates MS, Dolan PD, Chen S, Liby KT, Sporn MB, et al. Genetic or pharmacologic amplification of Nrf2 signaling inhibits acute inflammatory liver injury in mice. Toxicol Sci. 2008;104:218\u201327.","journal-title":"Toxicol Sci"},{"key":"1329_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","volume":"181","author":"NG Innamorato","year":"2008","unstructured":"Innamorato NG, Rojo AI, Garc\u00eda-Yag\u00fce AJ, Yamamoto M, de Ceballos ML, Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol. 2008;181:680\u20139.","journal-title":"J Immunol"},{"key":"1329_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419\u201330.","journal-title":"Immunity"},{"key":"1329_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E, Aksentijevi\u0107 D, Sundier SY, Robb EL, et al. Ischemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431\u20135.","journal-title":"Nature"},{"key":"1329_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167:457\u201370.","journal-title":"Cell"},{"key":"1329_CR26","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1126\/science.aav4011","volume":"366","author":"J Kim","year":"2019","unstructured":"Kim J, Gupta R, Blanco LP, Yang S, Shteinfer-Kuzmine A, Wang K, et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science. 2019;366:1531\u20136.","journal-title":"Science"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01329-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:51:05Z","timestamp":1769136665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01329-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01329-9","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Ethics Review Committee of the Laboratory Animal Center of Hebei University of Traditional Chinese Medicine (Approval number: DWLL202203037).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Meng Wang serves as a member of the Youth Editorial Board of Chinese Medicine. The author was not involved in the review or decision-making process for this manuscript. The authors declare no other conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}